Long-term follow-up after stent graft placement for access-site and access-related vascular injury during TAVI - The Bonn-Copenhagen experience
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Long-term follow-up after stent graft placement for access-site and access-related vascular injury during TAVI - The Bonn-Copenhagen experience. / Sedaghat, Alexander; Hansen, Kristoffer Lindskov; Schahab, Nadjib; May, Maria Cesarina; Weber, Marcel; Stundl, Anja; Shamekhi, Jasmin; Schaefer, Christian; Nickenig, Georg; Sinning, Jan-Malte; Lönn, Lars; Søndergaard, Lars; Werner, Nikos; De Backer, Ole.
In: International Journal of Cardiology, Vol. 281, 15.04.2019, p. 42-46.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Long-term follow-up after stent graft placement for access-site and access-related vascular injury during TAVI - The Bonn-Copenhagen experience
AU - Sedaghat, Alexander
AU - Hansen, Kristoffer Lindskov
AU - Schahab, Nadjib
AU - May, Maria Cesarina
AU - Weber, Marcel
AU - Stundl, Anja
AU - Shamekhi, Jasmin
AU - Schaefer, Christian
AU - Nickenig, Georg
AU - Sinning, Jan-Malte
AU - Lönn, Lars
AU - Søndergaard, Lars
AU - Werner, Nikos
AU - De Backer, Ole
N1 - Copyright © 2019 Elsevier B.V. All rights reserved.
PY - 2019/4/15
Y1 - 2019/4/15
N2 - AIMS: Stent graft placement is a safe and effective treatment option for vascular complications in the context of transcatheter aortic valve implantation (TAVI). This study aimed to provide long-term angiological follow-up of stent grafts used for this indication.METHODS AND RESULTS: Seventy-one patients (64.8% female, log EuroScore 14.7 ± 6.8%) who had undergone TAVI between March 2010 and October 2015 with implantation of a Viabahn or Fluency stent graft to treat access-site or access-related vascular injury (ASARVI) were analyzed. Implantations were mostly due to access-site bleeding complications (83.1%) in the common femoral artery (97.1%). Follow-up was performed with duplex sonography in all patients after a median of 3.9 years after TAVI (interquartile range [IQR]: 895-1749 days). Ultrasound revealed tri- or biphasic flow patterns in 16.9% and 77.6%, respectively. Stent graft patency was 100% without signs of stent graft stenosis (mean peak velocity ratio 1.0 ± 0.2). Pseudo-aneurysms or endoleaks were diagnosed in 5.6% of patients. Additional fluoroscopic and/or computed tomography (CT)-imaging was available in 36.6% of patients and did not reveal any stent fracture.CONCLUSION: Self-expanding stent grafts provide excellent long-term function with few complications when implanted in the context of TAVI-related ASARVI.
AB - AIMS: Stent graft placement is a safe and effective treatment option for vascular complications in the context of transcatheter aortic valve implantation (TAVI). This study aimed to provide long-term angiological follow-up of stent grafts used for this indication.METHODS AND RESULTS: Seventy-one patients (64.8% female, log EuroScore 14.7 ± 6.8%) who had undergone TAVI between March 2010 and October 2015 with implantation of a Viabahn or Fluency stent graft to treat access-site or access-related vascular injury (ASARVI) were analyzed. Implantations were mostly due to access-site bleeding complications (83.1%) in the common femoral artery (97.1%). Follow-up was performed with duplex sonography in all patients after a median of 3.9 years after TAVI (interquartile range [IQR]: 895-1749 days). Ultrasound revealed tri- or biphasic flow patterns in 16.9% and 77.6%, respectively. Stent graft patency was 100% without signs of stent graft stenosis (mean peak velocity ratio 1.0 ± 0.2). Pseudo-aneurysms or endoleaks were diagnosed in 5.6% of patients. Additional fluoroscopic and/or computed tomography (CT)-imaging was available in 36.6% of patients and did not reveal any stent fracture.CONCLUSION: Self-expanding stent grafts provide excellent long-term function with few complications when implanted in the context of TAVI-related ASARVI.
KW - Aged
KW - Aged, 80 and over
KW - Blood Vessel Prosthesis/adverse effects
KW - Cohort Studies
KW - Cross-Sectional Studies
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Male
KW - Stents/adverse effects
KW - Time Factors
KW - Tomography, X-Ray Computed/trends
KW - Transcatheter Aortic Valve Replacement/adverse effects
KW - Treatment Outcome
KW - Vascular System Injuries/diagnostic imaging
U2 - 10.1016/j.ijcard.2018.12.053
DO - 10.1016/j.ijcard.2018.12.053
M3 - Journal article
C2 - 30711261
VL - 281
SP - 42
EP - 46
JO - International Journal of Cardiology
JF - International Journal of Cardiology
SN - 0167-5273
ER -
ID: 235000881